PeptideDB

Fonadelpar

CAS: 515138-06-4 F: C25H23F3N2O4S W: 504.52

Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy.
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy.
Invitro Fonadelpar is a PPARδ agonist, used in the research of neuroparalytic keratopathy[1].
Name Fonadelpar
CAS 515138-06-4
Formula C25H23F3N2O4S
Molar Mass 504.52
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Reference [1]. Kobayashi, et al. Therapeutic agent for neuroparalytic keratopathy containing benzisoxazol compound-​based PPARδ agonist. WO2016199871A1.